Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Desogestrel is a progestin medication which is used in birth control pills. It is also used in the treatment of menopausal symptoms in women. The medication is available and used alone or in combination with an estrogen. It is taken by mouth.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Desogestrel.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Desogestrel shows recurring relationship patterns in the source. For example, Desogestrel → Alenvona, Apri, Azalia, Azurette, Bekyree, Caziant, Cerazette, Cerelle, Cesia, Cyclessa, Cyred, Denise, Desirett, Desogen, Diamilla, Emoquette, Enskyce, Feanolla, Gedarel, Gracial Another extracted example is Desogestrel → Accumulation, C11, C3, CYP3A4, Etonogestrel, Following, Hydroxylation, It, Neither, P450, P450-dependent, Peak, SHBG, Steady-state, The, This, While. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
etonogestrel effects activity used available affinity androgenic may day ethinylestradiol μg levels also oral progestogenic testosterone progesterone norethisterone women combination
TTTA extracted 177 structured relationships around Desogestrel. Examples in this analysis include Desogestrel → 3D model (JSmol) → Interactive image and Desogestrel → AHFS/Drugs.com → Multum Consumer Information. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Desogestrel | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Desogestrel | AHFS/Drugs.com | Multum Consumer Information | 1.00 | infobox |
| Desogestrel | ATC code | G03AC09 (WHO) | 1.00 | infobox |
| Desogestrel | Bioavailability | 76% (range 40–100%) | 1.00 | infobox |
| Desogestrel | CAS Number | 54024-22-5 Y | 1.00 | infobox |
| Desogestrel | ChEBI | CHEBI:4453 Y | 1.00 | infobox |
| Desogestrel | ChEMBL | ChEMBL1533 Y | 1.00 | infobox |
| Desogestrel | ChemSpider | 37400 Y | 1.00 | infobox |
| Desogestrel | CompTox Dashboard (EPA) | DTXSID6022898 | 1.00 | infobox |
| Desogestrel | Drug class | Progestogen | 1.00 | infobox |
| Desogestrel | DrugBank | DB00304 Y | 1.00 | infobox |
| Desogestrel | ECHA InfoCard | 100.053.555 | 1.00 | infobox |
| Desogestrel | Elimination half-life | Desogestrel: 1.5 hours Etonogestrel: 21–38 hrs | 1.00 | infobox |
| Desogestrel | Excretion | Urine: 50% Feces: 35% | 1.00 | infobox |
| Desogestrel | Formula | C22H30O | 1.00 | infobox |
| Desogestrel | IUPHAR/BPS | 7065 | 1.00 | infobox |
| Desogestrel | KEGG | D02367 Y | 1.00 | infobox |
| Desogestrel | Legal status | UK: POM (Prescription only) / P | 1.00 | infobox |
| Desogestrel | Legal status | US: ℞-only | 1.00 | infobox |
| Desogestrel | License data | US DailyMed: Desogestrel | 1.00 | infobox |
| Desogestrel | MedlinePlus | a601050 | 1.00 | infobox |
| Desogestrel | Melting point | 109 to 110 °C (228 to 230 °F) | 1.00 | infobox |
| Desogestrel | Metabolism | Liver, intestines (5α- and 5β-reductase, cytochrome P450 enzymes, others) | 1.00 | infobox |
| Desogestrel | Metabolites | • Etonogestrel • Others | 1.00 | infobox |
| Desogestrel | Molar mass | 310.481 g·mol−1 | 1.00 | infobox |
| Desogestrel | Other names | DSG; ORG-2969; 3-Deketo-11-methylene-17α-ethynyl-18-methyl-19-nortestosterone; 11-Methylene-17α-ethynyl-18-methylestr-4-en-17β-ol | 1.00 | infobox |
| Desogestrel | Protein binding | Desogestrel: 99%: • Albumin: 99% Etonogestrel: 95–98%: • Albumin: 65–66% • SHBGTooltip sex hormone-binding globulin: 30–32% • Free: 2–5% | 1.00 | infobox |
| Desogestrel | PubChem CID | 40973 | 1.00 | infobox |
| Desogestrel | Routes of administration | By mouth | 1.00 | infobox |
| Desogestrel | Trade names | Cerazette, Lovima, Hana, others | 1.00 | infobox |
The concept neighborhoods around Desogestrel bring nearby vocabulary together. In this analysis, examples include Etonogestrel, Effects and Activity. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Desogestrel, one of the stronger structural bridges in this analysis connects Desogestrel with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Desogestrel to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Desogestrel · EN edition · Analysis: TopicsToTalkAbout